Africa Health Research Institute NPC
Durban, Kwazulu-Natal, South Africa
Purpose
To evaluate immunology endpoints and Human Leukocyte Antigen (HLA) expression in participants in the C114 trial
Division
Global Health
Date
November 2024
Region Served
AFRICA
Committed amount
$4,700,000
Grant topic
HIV
Duration (months)
34
Grantee location
Durban, Kwazulu-Natal, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.